Stockscreener 앱 받기
1.65
1.23%
0.02
시간 외 거래:
1.62
-0.03
-1.82%
Atai Life Sciences N V 주식(ATAI)의 최신 뉴스
ATAI Explores Psychedelic Solutions for Veterans' Mental Health - GuruFocus
ATAI Explores Psychedelic Solutions for Veterans' Mental Health | ATAI Stock News - GuruFocus
Atai Life Sciences: Progress in Psychedelic Mental Health Treatments - TipRanks
Will Atai Get A New Lease Of Life? - RTTNews
Atai Life Sciences Reports First Quarter 2025 Financial Results - marketscreener.com
ATAI Reports Significant First Quarter Revenue Growth | ATAI Sto - GuruFocus
ATAI Sees Financial Boost with Cash Reserves Rise | ATAI Stock N - GuruFocus
ATAI Reports Significant First Quarter Revenue Growth | ATAI Stock News - GuruFocus
atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates - The Manila Times
Certain Options of Atai Life Sciences N.V. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com
ATAI Begins Phase 2 Study for Social Anxiety Treatment | ATAI St - GuruFocus
Atai Life Sciences Announces First Patient Dosed In Phase 2 Study Of Emp-01 For The Treatment Of Social Anxiety Disorder - marketscreener.com
atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder - Yahoo
ATAI Life Sciences Repays Hercules Loan Early - TipRanks
Daily Market Movement: ATAI Life Sciences N.V (ATAI) Sees a -2.00 Decrease, Closing at 1.47 - DWinneX
ATAI Life Sciences N.V [ATAI] Records 50-Day SMA of $1.4948 - knoxdaily.com
ATAI Life Sciences N.V: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - investchronicle.com
Have you been able to find a good deal on ATAI Life Sciences N.V’s shares? - uspostnews.com
Atai Life Sciences N.V. Announces Executive Changes - marketscreener.com
ATAI Life Sciences N.V (ATAI)’s Market Momentum: Closing Strong at 1.51, Down -3.82 - DWinneX
An Analysis of ATAI Life Sciences N.V (ATAI)’s Potential Price Growth - knoxdaily.com
ATAI’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
ATAI Life Sciences N.V [ATAI] stock for 65,560 USD was sold by Kirpekar Sahil - knoxdaily.com
How Will ATAI Life Sciences N.V (NASDAQ: ATAI) Perform In Months To Come? - Marketing Sentinel
Investing in ATAI Life Sciences N.V (ATAI) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
Atai Life Sciences: Pipeline And Regulatory Uncertainties Warrant Hold Rating - Seeking Alpha
Psyence BioMed invests half a million into natural psychedelics operator PsyLabs - Mugglehead Magazine
At What Point In Time Would I Choose To Purchase ATAI Life Sciences N.V (NASDAQ: ATAI) Stock? - stocksregister.com
A stock that deserves closer examination: ATAI Life Sciences N.V (ATAI) - uspostnews.com
Psychedelic Drugs Market Future Business Opportunities - openPR.com
ATAI Life Sciences N.V (NASDAQ: ATAI) Is Currently -99.23 Percent Below Its 52-Week High, But It Still Offers Strong Upside Potential. – Marketing Sentinel - Marketing Sentinel
Investor’s Delight: ATAI Life Sciences N.V (ATAI) Closes Weak at 1.27, Down -3.05 - DWinneX
Berenberg starts atai Life Sciences coverage with Positive rating By Investing.com - Investing.com Australia
Berenberg starts atai Life Sciences coverage with Positive rating - Investing.com
ATAI Life Sciences N.V (ATAI) Volatility Hits 10.40% – Here’s What A Good Investor Should Do - Stocksregister
Is Atai Life Sciences (ATAI) the Best German Stock to Buy According to Hedge Funds? - Insider Monkey
Is it possible to buy ATAI Life Sciences N.V(ATAI) shares at a good price now? - uspostnews.com
How Are Things Looking For ATAI Life Sciences N.V (NASDAQ: ATAI) For The Short Term? - stocksregister.com
ATAI Life Sciences N.V (ATAI) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
Insiders Make Huge Purchases of These 4 Biotech Stocks - 24/7 Wall St.
Atai Life Sciences chief scientific officer sells $17,767 in shares By Investing.com - Investing.com India
Atai Life Sciences CEO Rao Srinivas sells $101,814 in common shares By Investing.com - Investing.com South Africa
Atai life sciences CMO Craig James sells $15,610 in shares By Investing.com - Investing.com South Africa
Atai Life Sciences chief business officer sells $65,560 in stock By Investing.com - Investing.com South Africa
Atai Life Sciences chief business officer sells $65,560 in stock - Investing.com India
Atai Life Sciences CFO sells shares worth $45,285 - Investing.com India
Atai life sciences CMO Craig James sells $15,610 in shares - Investing.com India
Atai Life Sciences chief scientific officer sells $17,767 in shares - Investing.com
Atai Life Sciences director Angermayer buys $2.52 million in shares By Investing.com - Investing.com UK
Atai Life Sciences director Angermayer buys $2.52 million in shares - Investing.com
Psychedelic: atai Life Sciences, NRx report quarterly results - Yahoo Finance
Drug developers show mixed performance in early 2025 - BioWorld MedTech
Nasdaq-Listed Biotech Firm Atai Life Sciences to Launch Bitcoin Treasury Strategy - Cryptonews
ATAI Life Sciences invests $5M in Bitcoin as reserve asset By Investing.com - Investing.com Australia
atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights - The Manila Times
1.54%
7.58%
자본화:
|
볼륨(24시간):